References
- Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood. 2003;102(2):449–461. doi:https://doi.org/10.1182/blood-2002-12-3882.
- Rayes J, Watson SP, Nieswandt B. Functional significance of the platelet immune receptors GPVI and CLEC-2. J Clin Invest. 2019;129(1):12–23. doi:https://doi.org/10.1172/JCI122955.
- Best D, Senis YA, Jarvis GE, Eagleton HJ, Roberts DJ, Saito T, Jung SM, Moroi M, Harrison P, Green FR, et al. GPVI levels in platelets: relationship to platelet function at high shear. Blood. 2003;102(8):2811–2818. doi:https://doi.org/10.1182/blood-2003-01-0231.
- Clemetson JM, Polgar J, Magnenat E, Wells TN, Clemetson KJ. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem. 1999;274(41):29019–29024. doi:https://doi.org/10.1074/jbc.274.41.29019.
- Ezumi Y, Uchiyama T, Takayama H. Molecular cloning, genomic structure, chromosomal localization, and alternative splice forms of the platelet collagen receptor glycoprotein VI. Biochem Biophys Res Commun. 2000;277(1):27–36. doi:https://doi.org/10.1006/bbrc.2000.3624.
- Moroi M, Jung SM. Platelet glycoprotein VI: its structure and function. Thromb Res. 2004;114(4):221–233. doi:https://doi.org/10.1016/j.thromres.2004.06.046.
- Jandrot-Perrus M, Busfield S, Lagrue AH, Xiong X, Debili N, Chickering T, Le Couedic JP, Goodearl A, Dussault B, Fraser C, et al. Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood. 2000;96(5):1798–1807. doi:https://doi.org/10.1182/blood.V96.5.1798.
- Bori-Sanz T, Inoue KS, Berndt MC, Watson SP, Tulasne D. Delineation of the region in the glycoprotein VI tail required for association with the Fc receptor gamma-chain. J Biol Chem. 2003;278(38):35914–35922. doi:https://doi.org/10.1074/jbc.M301826200.
- Zheng YM, Liu C, Chen H, Locke D, Ryan JC, Kahn ML. Expression of the platelet receptor GPVI confers signaling via the Fc receptor gamma-chain in response to the snake venom convulxin but not to collagen. J Biol Chem. 2001;276(16):12999–13006. doi:https://doi.org/10.1074/jbc.M009344200.
- Feng J, Garrity D, Call ME, Moffett H, Wucherpfennig KW. Convergence on a distinctive assembly mechanism by unrelated families of activating immune receptors. Immunity. 2005;22(4):427–438. doi:https://doi.org/10.1016/j.immuni.2005.02.005.
- Berlanga O, Tulasne D, Bori T, Snell DC, Miura Y, Jung S, Moroi M, Frampton J, Watson SP. The Fc receptor gamma-chain is necessary and sufficient to initiate signalling through glycoprotein VI in transfected cells by the snake C-type lectin, convulxin. Eur J Biochem. 2002;269(12):2951–2960. doi:https://doi.org/10.1046/j.1432-1033.2002.02969.x.
- Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H. A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood. 1987;69(6):1712–1720. doi:https://doi.org/10.1182/blood.V69.6.1712.1712.
- Watson SP, Auger JM, McCarty OJT, Pearce AC. GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost. 2005;3(8):1752–1762. doi:https://doi.org/10.1111/j.1538-7836.2005.01429.x.
- Ezumi Y, Shindoh K, Tsuji M, Takayama H. Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor gamma chain complex on human platelets. J Exp Med. 1998;188(2):267–276. doi:https://doi.org/10.1084/jem.188.2.267.
- Suzuki-Inoue K, Tulasne D, Shen Y, Bori-Sanz T, Inoue O, Jung SM, Moroi M, Andrews RK, Berndt MC, Watson SP. Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling. J Biol Chem. 2002;277(24):21561–21566. doi:https://doi.org/10.1074/jbc.M201012200.
- Séverin S, Nash CA, Mori J, Zhao Y, Abram C, Lowell CA, Senis YA, Watson SP. Distinct and overlapping functional roles of Src family kinases in mouse platelets. J Thromb Haemost. 2012;10(8):1631–1645. doi:https://doi.org/10.1111/j.1538-7836.2012.04814.x.
- Hughes CE, Finney BA, Koentgen F, Lowe KL, Watson SP. The N-terminal SH2 domain of Syk is required for (hem)ITAM, but not integrin, signaling in mouse platelets. Blood. 2015;125(1):144–154. doi:https://doi.org/10.1182/blood-2014-05-579375.
- Haining EJ, Nicolson PLR, Onselaer MB, Poulter NS, Rayes J, Thomas MR, Watson SP. 11 - GPVI and CLEC-2. In: Michelson AD, editor. Platelets. 4th ed. Oxford, UK. Academic Press; 2019. p. 213–226.
- Slater A, Perrella G, Onselaer MB, Martin EM, Gauer JS, Xu RG, Heemskerk JW, Ariëns RAS, Watson SP. Does fibrin(ogen) bind to monomeric or dimeric GPVI, or not at all? Platelets. 2019;30(3):281–289. doi:https://doi.org/10.1080/09537104.2018.1508649.
- Vögtle T, Baig AA, Volz J, Duchow TB, Pleines I, Dütting S, Nitschke L, Watson SP, Nieswandt B. Critical redundant functions of the adapters Grb2 and Gads in platelet (hem)ITAM signaling in mice. Platelets. 2020;31(6):801–811. doi:https://doi.org/10.1080/09537104.2019.1709633
- Nicolson PLR, Hughes CE, Watson S, Nock SH, Hardy AT, Watson CN, Montague SJ, Clifford H, Huissoon AP, Malcor JD, et al. Inhibition of Btk by Btk-specific concentrations of ibrutinib and acalabrutinib delays but does not block platelet aggregation mediated by glycoprotein VI. Haematologica. 2018;103(12):2097–2108. doi:https://doi.org/10.3324/haematol.2018.193391.
- Series J, Garcia C, Levade M, Viaud J, Sie P, Ysebaert L, Payrastre B. Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions. Haematologica. 2019;104(11):2292–2299. doi:https://doi.org/10.3324/haematol.2018.207183.
- Bye AP, Unsworth AJ, Desborough MJ, Hildyard CAT, Appleby N, Bruce D, Kriek N, Nock SH, Sage T, Hughes CE, et al. Severe platelet dysfunction in NHL patients receiving ibrutinib is absent in patients receiving acalabrutinib. Blood Adv. 2017;1(26):2610–2623. doi:https://doi.org/10.1182/bloodadvances.2017011999.
- Morton LF, Hargreaves PG, Farndale RW, Young RD, Barnes MJ. Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity. Biochem J. 1995;306(2):337–344. doi:https://doi.org/10.1042/bj3060337.
- Poulter NS, Pollitt AY, Owen DM, Gardiner EE, Andrews RK, Shimizu H, Ishikawa D, Bihan D, Farndale RW, Moroi M, et al. Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets. J Thromb Haemost. 2017;15(3):549–564. doi:https://doi.org/10.1111/jth.13613.
- Knight CG, Morton LF, Onley DJ, Peachey AR, Ichinohe T, Okuma M, Farndale RW, Barnes MJ. Collagen-platelet interaction: gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc Res. 1999;41(2):450–457. doi:https://doi.org/10.1016/S0008-6363(98)00306-X.
- Murakami MT, Zela SP, Gava LM, Michelan-Duarte S, Cintra ACO, Arni RK. Crystal structure of the platelet activator convulxin, a disulfide-linked alpha4beta4 cyclic tetramer from the venom of Crotalus durissus terrificus. Biochem Biophys Res Commun. 2003;310(2):478–482. doi:https://doi.org/10.1016/j.bbrc.2003.09.032.
- Horii K, Brooks MT, Herr AB. Convulxin forms a dimer in solution and can bind eight copies of glycoprotein VI: implications for platelet activation. Biochemistry. 2009;48(13):2907–2914.
- Andrews RK, Gardiner EE, Asazuma N, Berlanga O, Tulasne D, Nieswandt B, Smith AI, Berndt MC, Watson SP. A novel viper venom metalloproteinase, alborhagin, is an agonist at the platelet collagen receptor GPVI. J Biol Chem. 2001;276(30):28092–28097. doi:https://doi.org/10.1074/jbc.M011352200.
- Nieswandt B, Bergmeier W, Schulte V, Rackebrandt K, Gessner JE, Zirngibl H. Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRgamma chain. J Biol Chem. 2000;275(31):23998–24002. doi:https://doi.org/10.1074/jbc.M003803200.
- Al-Tamimi M, Mu FT, Arthur JF, Shen Y, Moroi M, Berndt MC, Andrews RK, Gardiner EE. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding. Platelets. 2009;20(2):75–82. doi:https://doi.org/10.1080/09537100802645029
- Onselaer MB, Hardy AT, Wilson C, Sanchez X, Babar AK, Miller JLC, Watson CN, Watson SK, Bonna A, Philippou H, et al. Fibrin and D-dimer bind to monomeric GPVI. Blood Adv. 2017;1(19):1495–1504. doi:https://doi.org/10.1182/bloodadvances.2017007732.
- Mammadova-Bach E, Ollivier V, Loyau S, Schaff M, Dumont B, Favier R, Freyburger G, Latger-Cannard V, Nieswandt B, Gachet C, et al. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation. Blood. 2015;126(5):683–691. doi:https://doi.org/10.1182/blood-2015-02-629717.
- Ebrahim M, Jamasbi J, Adler K, Megens RTA, M’Bengue Y, Blanchet X, Uhland K, Ungerer M, Brandl R, Weber C, et al. Dimeric glycoprotein VI binds to collagen but not to fibrin. Thromb Haemost. 2018;118(2):351–361. doi:https://doi.org/10.1160/TH17-04-0302.
- Alshehri OM, Hughes CE, Montague S, Watson SK, Frampton J, Bender M, Watson SP. Fibrin activates GPVI in human and mouse platelets. Blood. 2015;126(13):1601–1608. doi:https://doi.org/10.1182/blood-2015-04-641654.
- Induruwa I, Moroi M, Bonna A, Malcor JD, Howes JM, Warburton EA, Farndale RW, Jung SM. Platelet collagen receptor Glycoprotein VI-dimer recognizes fibrinogen and fibrin through their D-domains, contributing to platelet adhesion and activation during thrombus formation. J Thromb Haemost. 2018;16(2):389–404. doi:https://doi.org/10.1111/jth.13919.
- Mangin PH, Onselaer MB, Receveur N, Le Lay N, Hardy AT, Wilson C, Sanchez X, Loyau S, Dupuis A, Babar AK, et al. Immobilized fibrinogen activates human platelets through glycoprotein VI. Haematologica. 2018;103(5):898–907. doi:https://doi.org/10.3324/haematol.2017.182972.
- Inoue O, Suzuki-Inoue K, McCarty OJT, Moroi M, Ruggeri ZM, Kunicki TJ, Ozaki Y, Watson SP. Laminin stimulates spreading of platelets through integrin alpha6beta1-dependent activation of GPVI. Blood. 2006;107(4):1405–1412. doi:https://doi.org/10.1182/blood-2005-06-2406.
- Bültmann A, Li Z, Wagner S, Peluso M, Schönberger T, Weis C, Konrad I, Stellos K, Massberg S, Nieswandt B, et al. Impact of glycoprotein VI and platelet adhesion on atherosclerosis–a possible role of fibronectin. J Mol Cell Cardiol. 2010;49(3):532–542. doi:https://doi.org/10.1016/j.yjmcc.2010.04.009.
- Maurer E, Schaff M, Receveur N, Bourdon C, Mercier L, Nieswandt B, Dubois C, Jandrot-Perrus M, Goetz JG, Lanza F, et al. Fibrillar cellular fibronectin supports efficient platelet aggregation and procoagulant activity. Thromb Haemost. 2015;114(6):1175–1188. doi:https://doi.org/10.1160/TH14-11-0958.
- Schönberger T, Ziegler M, Borst O, Konrad I, Nieswandt B, Massberg S, Ochmann C, Jürgens T, Seizer P, Langer H, et al. The dimeric platelet collagen receptor GPVI-Fc reduces platelet adhesion to activated endothelium and preserves myocardial function after transient ischemia in mice. Am J Physiol Cell Physiol. 2012;303(7):C757–C766. doi:https://doi.org/10.1152/ajpcell.00060.2012.
- Riba R, Hughes CE, Graham A, Watson SP, Naseem KM. Globular adiponectin induces platelet activation through the collagen receptor GPVI-Fc receptor gamma chain complex. J Thromb Haemost. 2008;6(6):1012–1020. doi:https://doi.org/10.1111/j.1538-7836.2008.02982.x.
- Elaskalani O, Khan I, Morici M, Matthysen C, Sabale M, Martins RN, Verdile G, Metharom P. Oligomeric and fibrillar amyloid beta 42 induce platelet aggregation partially through GPVI. Platelets. 2018;29(4):415–420. doi:https://doi.org/10.1080/09537104.2017.1401057.
- Seizer P, Borst O, Langer HF, Bültmann A, Münch G, Herouy Y, Stellos K, Krämer B, Bigalke B, Büchele B, et al. EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction. Thromb Haemost. 2009;101(4):682–686. doi:https://doi.org/10.1160/TH08-06-0368.
- Schulz C, von Brühl ML, Barocke V, Cullen P, Mayer K, Okrojek R, Steinhart A, Ahmad Z, Kremmer E, Nieswandt B, et al. EMMPRIN (CD147/basigin) mediates platelet-monocyte interactions in vivo and augments monocyte recruitment to the vascular wall. J Thromb Haemost. 2011;9(5):1007–1019. doi:https://doi.org/10.1111/j.1538-7836.2011.04235.x
- Alshehri OM, Montague S, Watson S, Carter P, Sarker N, Manne BK, Miller JLC, Herr AB, Pollitt AY, O’Callaghan CA, et al. Activation of glycoprotein VI (GPVI) and C-type lectin-like receptor-2 (CLEC-2) underlies platelet activation by diesel exhaust particles and other charged/hydrophobic ligands. Biochem J. 2015;468(3):459–473. doi:https://doi.org/10.1042/BJ20150192.
- Snell DC, Schulte V, Jarvis GE, Arase K, Sakurai D, Saito T, Watson SP, Nieswandt B. Differential effects of reduced glycoprotein VI levels on activation of murine platelets by glycoprotein VI ligands. Biochem J. 2002;368(Pt 1):293–300. doi:https://doi.org/10.1042/bj20020335.
- Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, Barnes MJ. The collagen-binding A-domains of integrins α1β1 and α2β1 recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem. 2000;275(1):35–40. doi:https://doi.org/10.1074/jbc.275.1.35.
- Lecut C, Feeney LA, Kingsbury G, Hopkins J, Lanza F, Gachet C, Villeval JL, Jandrot-Perrus M. Human platelet glycoprotein VI function is antagonized by monoclonal antibody-derived Fab fragments. J Thromb Haemost. 2003;1(12):2653–2662. doi:https://doi.org/10.1111/j.1538-7836.2003.00495.x.
- Niedergang F, Alcover A, Knight CG, Farndale RW, Barnes MJ, Francischetti IM, Bon C, Leduc M. Convulxin binding to platelet receptor GPVI: competition with collagen related peptides. Biochem Biophys Res Commun. 2000;273(1):246–250. doi:https://doi.org/10.1006/bbrc.2000.2940.
- Du XY, Clemetson JM, Navdaev A, Magnenat EM, Wells TN, Clemetson KJ. Ophioluxin, a convulxin-like C-type lectin from Ophiophagus hannah (King cobra) is a powerful platelet activator via glycoprotein VI. J Biol Chem. 2002;277(38):35124–35132. doi:https://doi.org/10.1074/jbc.M204372200.
- Asazuma N, Marshall SJ, Berlanga O, Snell D, Poole AW, Berndt MC, Andrews RK, Watson SP. The snake venom toxin alboaggregin-A activates glycoprotein VI. Blood. 2001;97(12):3989–3991. doi:https://doi.org/10.1182/blood.V97.12.3989.
- Dormann D, Clemetson JM, Navdaev A, Kehrel BE, Clemetson KJ. Alboaggregin A activates platelets by a mechanism involving glycoprotein VI as well as glycoprotein Ib. Blood. 2001;97(4):929–936. doi:https://doi.org/10.1182/blood.V97.4.929.
- Du XY, Magnenat E, Wells TN, Clemetson KJ. Alboluxin, a snake C-type lectin from Trimeresurus albolabris venom is a potent platelet agonist acting via GPIb and GPVI. Thromb Haemost. 2002;87(4):692–698. doi:https://doi.org/10.1055/s-0037-1613067.
- Miura Y, Takahashi T, Jung SM, Moroi M. Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI) with collagen. A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen. J Biol Chem. 2002;277(48):46197–46204. doi:https://doi.org/10.1074/jbc.M204029200.
- Horii K, Kahn ML, Herr AB. Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI. Blood. 2006;108(3):936–942. doi:https://doi.org/10.1182/blood-2006-01-010215.
- Berlanga O, Bori-Sanz T, James JR, Frampton J, Davis SJ, Tomlinson MG, Watson SP. Glycoprotein VI oligomerization in cell lines and platelets. J Thromb Haemost. 2007;5(5):1026–1033. doi:https://doi.org/10.1111/j.1538-7836.2007.02449.x.
- Arthur JF, Shen Y, Kahn ML, Berndt MC, Andrews RK, Gardiner EE. Ligand binding rapidly induces disulfide-dependent dimerization of glycoprotein VI on the platelet plasma membrane. J Biol Chem. 2007;282(42):30434–30441. doi:https://doi.org/10.1074/jbc.M701330200.
- Jung SM, Tsuji K, Moroi M. Glycoprotein (GP) VI dimer as a major collagen-binding site of native platelets: direct evidence obtained with dimeric GPVI-specific Fabs. J Thromb Haemost. 2009;7(8):1347–1355. doi:https://doi.org/10.1111/j.1538-7836.2009.03496.x.
- Jung SM, Moroi M, Soejima K, Nakagaki T, Miura Y, Berndt MC, Gardiner EE, Howes JM, Pugh N, Bihan D, et al. Constitutive dimerization of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood. J Biol Chem. 2012;287(35):30000–30013. doi:https://doi.org/10.1074/jbc.M112.359125.
- Loyau S, Dumont B, Ollivier V, Boulaftali Y, Feldman L, Ajzenberg N, Jandrot-Perrus M. Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity. Arterioscler Thromb Vasc Biol. 2012;32(3):778–785. doi:https://doi.org/10.1161/ATVBAHA.111.241067.
- Clark JC, Kavanagh DM, Watson S, Pike JA, Andrews RK, Gardiner EE, Poulter NS, Hill SJ, Watson SP. Adenosine and forskolin inhibit platelet aggregation by collagen but not the proximal signalling events. Thromb Haemost. 2019;119(7):1124–1137. doi:https://doi.org/10.1055/s-0039-1688788.
- Tomlinson MG, Calaminus SD, Berlanga O, Auger JM, Bori-Sanz T, Meyaard L, Watson SP. Collagen promotes sustained glycoprotein VI signaling in platelets and cell lines. J Thromb Haemost. 2007;5(11):2274–2283. doi:https://doi.org/10.1111/j.1538-7836.2007.02746.x.
- Arthur JF, Gardiner EE, Matzaris M, Taylor SG, Wijeyewickrema L, Ozaki Y, Kahn ML, Andrews RK, Berndt MC. Glycoprotein VI is associated with GPIb-IX-V on the membrane of resting and activated platelets. Thromb Haemost. 2005;93(4):716–723. doi:https://doi.org/10.1160/TH04-09-0584.
- Pishko AM, Andrews RK, Gardiner EE, Lefler DS, Cuker A. Soluble glycoprotein VI is a predictor of major bleeding in patients with suspected heparin-induced thrombocytopenia. Blood Adv. 2020;4(18):4327–4332. doi:https://doi.org/10.1182/bloodadvances.2020002861.